Australia's Lumos rises after FDA grants emergency-use authorisation for ViraDx

Lumos Diagnostics Holdings

11/09/2023 01:33

** Shares of Lumos Diagnostics Holdings Ltd  LDX.AX  up as
much as 15.8% at A$0.11, their highest since Aug 31  
    ** The diagnostics solutions provider says the U.S. FDA
granted emergency-use authorisation (EUA) For ViraDx, which is a
rapid POC test that simultaneously tests for acute respiratory
infections caused by the COVID-19, influenza A, and influenza B
viruses 
    ** As part of the EUA, the FDA has requested some
post-marketing studies that may require additional investment in
the future, co says 
    ** Lumos stock up 97.9% this year, as of last close 

    

 (Reporting by Aishwarya Nair in Bengaluru)